According to the Department of Health & Human Services, beginning January 15, 2022, individuals with private health insurance coverage or covered by a group health plan who purchase an over-the-counter COVID-19 diagnostic test authorized, cleared, or approved by the U.S. Food and Drug Administration (FDA) will be able to have those test costs covered by their plan or insurance.
Insurance companies and health plans are required to cover 8 free over-the-counter at-home tests per covered individual per month.
You can find out from your plan or insurer on how to submit a claim to your insurance company for reimbursement. The following list shows information your plan or insurer may require when submitting a claim for iHealth COVID-19 Antigen Rapid Test.
1. UPC Code: 856362005890
2. NDC Code: 56362-0005-89
3. TAX ID (EIN): 80-0664152
4. NPI: 1710514476
5. Address: iHealth Labs, Inc., 880 W Maude Ave, Sunnyvale CA 94085
6. Receipt showing the date of purchase and testing kit charges
Please note that you have to contact your insurance company for the detailed reimbursement policy. If you need any other supporting documents in addition to the above listed information, please send an email to support@ihealthlabs.com
For more questions regarding insurance coverage on the cost of at-home COVID-19 tests, please visit:
Update:
As of May 11th, 2023 the Public Health Emergency for COVID-19 has ended.
Coverage for COVID-19 testing for Americans will change. Medicare beneficiaries who are enrolled in Part B will continue to have coverage without cost sharing for laboratory-conducted COVID-19 tests when ordered by a provider, but their current access to free over-the-counter (OTC) COVID-19 tests will end, consistent with the statute on Medicare payment for OTC tests set by Congress.
The requirement for private insurance companies to cover COVID-19 tests without cost sharing, both for OTC and laboratory tests, will end. However, coverage may continue if plans choose to continue to include it. We are encouraging private insurers to continue to provide such coverage going forward.
State Medicaid programs must provide coverage without cost sharing for COVID-19 testing until the last day of the first calendar quarter that begins one year after the last day of the COVID-19 PHE. That means with the COVID-19 PHE ending on May 11, 2023, this mandatory coverage will end on September 30, 2024, after which coverage may vary by state.
Additionally, dependent on supply and resources, the USG may continue to distribute free COVID-19 tests from the Strategic National Stockpile through the United States Postal Service, states, and other community partners. Pending resource availability, the Centers for Disease Control and Prevention’s (CDC) Increasing Community Access to Testing (ICATT) program will continue working to ensure continued equitable access to testing for uninsured individuals and areas of high social vulnerability through pharmacies and community-based sites.